{"id": "1338484638579351553", "creation": 1607954580.0, "user_id": "1053359667995463682", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 8, "quote_count": 1}}, "text": "Two #BioNTech #vaccine candidates, based on mRNAs for the glycoprotein spike of #SARSCoV2 and lipid nanoparticles, in mice elicit a dose-dependent #antibody response and strong T-cell responses and protect macaques. Phase 1/2 trials are ongoing.\nhttps://t.co/mUc6fa7E0X #COVID19 https://t.co/1RJkwiplCc", "first_save": 1634559108.199414, "hashtags": ["#BIONTECH", "#VACCINE", "#SARSCOV2", "#ANTIBODY", "#COVID19"]}